DSIP, or Delta Sleep-Inducing Peptide, is a nonapeptide first characterized from rabbit cerebral blood in the late 1970s and studied since for its reported links to slow-wave sleep, stress physiology, and neuroendocrine signaling. Its name describes an effect researchers observed in animal EEG recordings — not a guarantee of how it behaves in every model, and not a clinical promise. Supplied strictly for laboratory research use (RUO).
HPLC certified
Independent analysis
Highest standard
Full traceability
Each order ships as a DSIP research compound in a 10mg vial, manufactured for laboratory use only.
| Compound | DSIP (Delta Sleep-Inducing Peptide) |
|---|---|
| Sequence | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (nonapeptide), ≈849 Da -- published literature identity, not a batch-specific result |
| Research History | ~50 years (characterized 1977, sequenced/synthesized 1978 by Schoenenberger, Maier, Tobler & Monnier) |
| Mechanism Status | Unresolved -- no gene, receptor, or precursor confirmed in mammals as of the most recent dedicated review (2006) |
| Available Size | 10mg |
| Purity | Not independently verified -- no batch-specific COA is currently published |
| Identity | Not independently confirmed by mass spectrometry or an equivalent method |
| Intended Use | Laboratory research only (RUO) |
When your order arrives, match the lot number printed on the vial to the lot number on the COA before beginning any work. Until a batch-specific COA is published for this product, treat any purity or identity figure shown elsewhere on this listing as a supplier claim, not an independently verified result.
HCG and LH bind the exact same receptor — yet research shows they send measurably different signals once they do. Here's what's actually established about HCG's structure, mechanism, and the FDA's position on HCG weight-loss claims.
No peer-reviewed human study of IGF-1 LR3 exists — a 2026 literature review placed it in its lowest evidence tier. Here's what the cell and animal research actually shows, and where it stops.
BPC-157 sits in a different WADA category than TB-500 or ipamorelin — and that difference actually matters if you're trying to understand the rules. Here's the 2026 list, compound by compound, with the official source for each.
